Glycated Hemoglobin Level Goal Achievement in Adults With Type 2 Diabetes in Canada: Still Room for Improvement

Author:

Leiter Lawrence A.,Cheng Alice Y.Y.,Ekoé Jean-Marie,Goldenberg Ronald M.,Harris Stewart B.,Hramiak Irene M.,Khunti Kamlesh,Lin Peter J.,Richard Jean-François,Senior Peter A.,Yale Jean-François,Goldin Lianne,Tan Mary K.,Langer Anatoly

Funder

Merck

AstraZeneca

Boehringer Ingelheim

Lilly

GSK

Janssen

MSD

Novo Nordisk

Sanofi

Servier

Bristol-Myers Squibb

Takeda

Abbott

GlaxoSmithKline

Medtronic

Novartis

Roche

Insulet Corp

Janssen Pharmaceuticals

Lexicon Pharmaceuticals

Novo Nordisk

Roche Pharma

Sanofi-Aventis

Unilever

Bayer

Mylan

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference47 articles.

1. IDF diabetes atlas,2017

2. Diabetes Statistics in Canada,2018

3. Type 2 diabetes mellitus management in Canada: Is it improving?;Leiter;Can J Diabetes,2013

4. National Diabetes Audit, 2016–17. Care Processes and Treatment Targets: Short report,2017

5. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010;Stark Casagrande;Diabetes Care,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3